De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Constellium Balans Gezondheid
Financiële gezondheid criteriumcontroles 4/6
Constellium heeft een totaal eigen vermogen van €973.0M en een totale schuld van €1.7B, wat de schuld-eigenvermogensverhouding op 176.3% brengt. De totale activa en totale passiva bedragen respectievelijk €4.9B en €4.0B. De EBIT Constellium is €352.0M waardoor de rentedekking 3.8 is. Het heeft contanten en kortetermijnbeleggingen van €213.0M.
Belangrijke informatie
176.3%
Verhouding schuld/eigen vermogen
€1.72b
Schuld
| Rente dekkingsratio | 3.8x |
| Contant | €213.00m |
| Aandelen | €973.00m |
| Totaal verplichtingen | €3.97b |
| Totaal activa | €4.94b |
Recente financiële gezondheidsupdates
Is Constellium (NYSE:CSTM) Using Too Much Debt?
Mar 29
Constellium (NYSE:CSTM) Use Of Debt Could Be Considered Risky
Nov 23Here's Why Constellium (NYSE:CSTM) Is Weighed Down By Its Debt Load
Jul 27Constellium (NYSE:CSTM) Has No Shortage Of Debt
Apr 26Does Constellium (NYSE:CSTM) Have A Healthy Balance Sheet?
Jan 09Does Constellium (NYSE:CSTM) Have A Healthy Balance Sheet?
Jul 25Recent updates
Why We're Not Concerned About Constellium SE's (NYSE:CSTM) Share Price
May 21We Think That There Are More Issues For Constellium (NYSE:CSTM) Than Just Sluggish Earnings
May 01Earnings Miss: Constellium SE Missed EPS By 46% And Analysts Are Revising Their Forecasts
Apr 28Constellium SE (NYSE:CSTM) Shares Could Be 41% Below Their Intrinsic Value Estimate
Apr 16Is Constellium (NYSE:CSTM) Using Too Much Debt?
Mar 29Constellium (NYSE:CSTM) Is Doing The Right Things To Multiply Its Share Price
Mar 11Constellium: Solid Fundamentals And Attractive Valuation, Despite Macro Headwinds
Jan 29Constellium SE (NYSE:CSTM) Shares Could Be 30% Below Their Intrinsic Value Estimate
Jan 08Potential Upside For Constellium SE (NYSE:CSTM) Not Without Risk
Dec 18Constellium (NYSE:CSTM) Use Of Debt Could Be Considered Risky
Nov 23Constellium: Sensitivity To Exogenous Factors Capping Upside Potential, Rate Hold
Oct 26Are Investors Undervaluing Constellium SE (NYSE:CSTM) By 33%?
Sep 21Constellium: Strong Q2 2023 Results Support Long-Term Investment Thesis
Aug 03Here's Why Constellium (NYSE:CSTM) Is Weighed Down By Its Debt Load
Jul 27Constellium (NYSE:CSTM) Has No Shortage Of Debt
Apr 26Here's Why We Think Constellium (NYSE:CSTM) Is Well Worth Watching
Mar 13Constellium SE (NYSE:CSTM) Shares Could Be 41% Below Their Intrinsic Value Estimate
Feb 23Constellium Q4 2022 Earnings Preview
Feb 21Constellium sells Ussel plant
Feb 03Does Constellium (NYSE:CSTM) Have A Healthy Balance Sheet?
Jan 09An Intrinsic Calculation For Constellium SE (NYSE:CSTM) Suggests It's 45% Undervalued
Nov 17Constellium Q3 2022 Earnings Preview
Oct 25Constellium supplying aluminium Auto Body Sheet solutions to car manufacturer
Sep 13Do Constellium's (NYSE:CSTM) Earnings Warrant Your Attention?
Sep 06Constellium EPS of -€0.24, revenue of €2.28B beats by €240M
Jul 27Does Constellium (NYSE:CSTM) Have A Healthy Balance Sheet?
Jul 25Do Constellium's (NYSE:CSTM) Earnings Warrant Your Attention?
May 31Constellium: A Discounted Play On Secular Aluminum Tailwinds
Apr 25Constellium SE's (NYSE:CSTM) Intrinsic Value Is Potentially 97% Above Its Share Price
Mar 21Constellium: An Overlooked Automotive Transformation Vehicle
Dec 30Does Constellium (NYSE:CSTM) Have A Healthy Balance Sheet?
Dec 24Calculating The Fair Value Of Constellium SE (NYSE:CSTM)
Sep 10Constellium Is An Overlooked And Grossly Undervalued Opportunity
Aug 25Here's Why Constellium (NYSE:CSTM) Has A Meaningful Debt Burden
Jul 10Constellium rising as it's set to join Russell 3000 index
Jun 08Constellium (NYSE:CSTM) Is Posting Promising Earnings But The Good News Doesn’t Stop There
May 05Calculating The Intrinsic Value Of Constellium SE (NYSE:CSTM)
Apr 29Constellium Q1 2021 Earnings Preview
Apr 27Here's What Analysts Are Forecasting For Constellium SE (NYSE:CSTM) After Its Full-Year Results
Mar 01Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( €2.1B ) CSTM } overtreffen de korte termijn passiva ( €1.6B ).
Langlopende schulden: De kortetermijnactiva van CSTM ( €2.1B ) dekken de langetermijnschulden ( €2.4B ) niet.
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: De netto schuld/eigen vermogen ratio ( 154.4% ) CSTM wordt als hoog beschouwd.
Schuld verminderen: CSTM had 5 jaar geleden een negatief eigen vermogen, maar is nu positief en is dus verbeterd.
Schuldendekking: De schuld van CSTM wordt goed gedekt door de operationele kasstroom ( 31.8% ).
Rentedekking: De rentebetalingen op de schuld van CSTM worden goed gedekt door EBIT ( 3.8 x dekking).